Press release
Vascular Stent Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG
Vascular Stent Market Characteristics
The Business Research Company offers in-depth market insights through Vascular Stent Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The vascular stent market size has grown rapidly in recent years. It will grow from $14.74 billion in 2023 to $16.26 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to clinical research and development, drug-eluting stents (des), introduction of balloon angioplasty, early stent innovations, physician training and skill development..
The vascular stent market size is expected to see strong growth in the next few years. It will grow to $23.61 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to focus on preventive cardiovascular care, shift towards outpatient procedures, cost-effectiveness and value-based healthcare, bioabsorbable stents and next-generation materials, expansion of endovascular interventions.. Major trends in the forecast period include advancements in stent coatings and materials, patient education and awareness, shift towards outpatient settings, focus on cost-effectiveness..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp
Market Segmentation:
The vascular stent market covered in this report is segmented -
1) By Product: Coronary Stents, Peripheral Vascular Stents, Evar Stent Grafts
2) By Type: Bare Metal Stent, Bio-engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent
3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents
4) By Mode of Delivery: Balloon-expandable Stent, Self-expanding Stent
5) By End-user: Ambulatory Surgical Center, Cardiac Center, Hospital
Major Driver - Navigating Cardiovascular Health Surge In Vascular Diseases Propels Growth Of The Vascular Stent Market
Rise in the incidence of vascular diseases will propel the growth of the vascular stent market going forward. Vascular disease refers to an abnormal condition that affects the blood vessels (arteries and veins) and is part of the cardiovascular diseases (CVD) group. Vascular stents help in the treatment of various vascular diseases by enabling the supply of oxygen-rich blood to the heart. For instance, in May 2023, according to the Center for Disease Control and Prevention, a US-based federal agency for national public health, about 695,000 people in the United States died from heart disease in 2021, that's 1 in every 5 deaths. Therefore, an increase in cardiovascular diseases (CVDs) will drive the growth of the vascular stent market.
Competitive Landscape:
Major companies operating in the vascular stent market report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., Lombard Medical Technologies Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology (Beijing) Co. Ltd., Koninklijke Philips N.V., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Stryker Corporation, Osypka AG, Spectranetics Corporation, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., Siemens Healthineers AG, General Electric Company, Nihon Kohden Corporation, Fujifilm Corporation, EP Medsystems Inc., ZOLL Medical Corporation
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report
Top Trend - Translumina's Vivo Isar Sets The Pace In The Technologically Advanced Vascular Stent Market
Technological advancement is a key trend gaining popularity in the vascular stent market. Many companies are investing in bio-sensing devices, cutting-edge integrated stents, and drug-eluting coronary stent systems to gain a competitive edge in the market. For instance, in 2022, Translumina, an India-based medical equipment manufacturer launched VIVO ISAR, a latest generation dual drug polymer-free coated stent (DDCS) that brings together a stent with a superior safety profile without compromising the drug release kinetics. It uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenosis drug), and thus creates a polymer-free DES platform with uncompromised safety and efficacy.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Vascular Stent Market Characteristics
3. Vascular Stent Market Trends And Strategies
4. Vascular Stent Market - Macro Economic Scenario
5. Vascular Stent Market Size And Growth
…..
27. Vascular Stent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vascular Stent Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG here
News-ID: 3423799 • Views: …
More Releases from The Business research company
Future Perspective: Key Trends Shaping the Drafting Services Market Until 2030
The drafting services industry is poised for considerable expansion in the coming years as technological advancements and evolving construction needs drive demand. With a wide range of applications across sectors, this market is set to experience steady growth fueled by innovation and increasing adoption of digital tools. Let's explore the current market size, influential factors, key players, emerging trends, and segmentation in this dynamic field.
Projected Growth and Market Size of…
Emerging Sub-Segments Transforming the Digital Rights Management Market Landscap …
The digital rights management (DRM) market is positioned for remarkable expansion in the coming years, driven by technological advancements and increasing concerns over content security. As digital media consumption grows and new platforms emerge, DRM solutions are becoming essential to protect intellectual property and ensure the authorized use of digital assets. Let's explore the current market size, key players, prevailing trends, and the main segments shaping the future of this…
Market Trend Insights: The Impact of Recent Advances on the Damage Evaluation Se …
The damage evaluation service market is on the brink of substantial growth as advancements in technology and increasing demand for efficient damage assessment methods gain momentum. This sector is evolving rapidly with the integration of innovative tools and techniques that enhance accuracy and speed in evaluating damages across various industries.
Forecasted Market Size and Growth Trajectory of the Damage Evaluation Service Market
The damage evaluation service market is projected to…
Corporate Training Market: Segmentation Analysis, Market Trends, and Competitive …
The corporate training sector is on a path of significant growth as organizations increasingly recognize the importance of continuous employee development. With rapid technological advances and shifting workforce needs, this market is expected to expand steadily, driven by innovative solutions and evolving learning preferences. Below, we explore the market's size projections, key players, emerging trends, and segmentation insights to provide a comprehensive overview of the corporate training landscape.
Projected Growth and…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
